Table 2.
Characteristics of Endovascular Neurosurgical Cases During the Peak Period of the COVID-19 Pandemic
| Characteristic | Procedures (%) (n = 69) |
|---|---|
| Patient age, years, mean (SD) | 57 (±20) |
| Week | |
| 3/16–3/22 | 8 (11.6) |
| 3/23–3/29 | 4 (5.8) |
| 3/30–4/5 | 10 (14.5) |
| 4/6–4/12 | 8 (11.6) |
| 4/13–4/19 | 5 (7.2) |
| 4/20–4/26 | 10 (14.5) |
| 4/27–5/3 | 21 (30.4) |
| 5/4–5/5 | 3 (4.3) |
| Site | |
| Mount Sinai Hospital | 64 (92.8) |
| Mount Sinai West | 5 (7.2) |
| Type of procedure | |
| Diagnostic | 19 (27.5) |
| Interventional | 50 (72.5) |
| Pathology | |
| Stroke | 20 (29) |
| Central retinal artery occlusion | 1 (1.4) |
| Subarachnoid hemorrhage | 10 (14.5) |
| Vasospasm | 10 (14.5) |
| Ruptured aneurysm | 2 (2.9) |
| Unruptured aneurysm | 3 (4.3) |
| Arteriovenous malformation | 5 (7.2) |
| Vein of Galen malformation | 1 (1.4) |
| Subdural hematoma | 6 (8.7) |
| Venous sinus thrombosis | 2 (2.9) |
| Moyamoya disease | 1 (1.4) |
| Vessel stenosis | 3 (4.3) |
| Tumor | 2 (2.9) |
| Compression fracture | 1 (1.4) |
| Epistaxis | 2 (2.9) |
| COVID-19 status | |
| Negative | 48 (69.6) |
| Positive | 15 (21.7) |
| Unknown | 6 (8.7) |
| Number of swabs, mean (SD) | 2 (±0) |
| Surgical emergency | 44 (63.8) |
| COVID-19 case volume | 69 |
| Case volume decrease, January–February 2020 | 72.7% |
| Case volume decrease, March–May 2019 | 79.7% |
COVID-19, 2019 novel coronavirus disease.